Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever

NCT00063089 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Staphylococcal Infections

Interventions

DRUG: S. aureus Immune Globulin Intravenous (Human) 5%

Sponsor

Nabi Biopharmaceuticals